| Ellen Marie Farr, MD | |
|
2139 Auburn Ave Ste C920b, Cincinnati, OH 45219-2906 | |
| (513) 792-7441 | |
| (513) 791-4042 |
| Full Name | Ellen Marie Farr |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 2139 Auburn Ave Ste C920b, Cincinnati, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548701998 | NPI | - | NPPES |
| 0002318 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 35.1458421 (Ohio) | Primary |
| Entity Name | Stephen D Heis Md & Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396835708 PECOS PAC ID: 9335114404 Enrollment ID: O20040901000201 |
News Archive
Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced the pricing of a previously announced underwritten public offering of 3,200,000 shares of its common stock, offered at a price to the public of $0.95 per share.
Research from the Oklahoma Medical Research Foundation reveals a new complexity to nerve cells in the brain that could affect future therapies aimed at altering mood and memory in humans.
Pioneering neural recordings in patients with Parkinson's disease by UC San Francisco scientists lays the groundwork for personalized brain stimulation to treat Parkinson's and other neurological disorders.
Twenty-six scientists have received a total of $2.06 million in grants from the National Psoriasis Foundation to study psoriasis—the most common autoimmune disease in the country, affecting as many as 7.5 million Americans—and psoriatic arthritis, an inflammatory joint and tendon disease.
There is an exponential use of food additives, especially processed food, due to the significant growth of the global population, changes in lifestyle patterns and demand for nutritious, safe, colourful, flavourful, affordable and convenient food.
› Verified 1 days ago
| Entity Name | Christ Hospital Orthopedic Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376859181 PECOS PAC ID: 1456477355 Enrollment ID: O20100929000030 |
News Archive
Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced the pricing of a previously announced underwritten public offering of 3,200,000 shares of its common stock, offered at a price to the public of $0.95 per share.
Research from the Oklahoma Medical Research Foundation reveals a new complexity to nerve cells in the brain that could affect future therapies aimed at altering mood and memory in humans.
Pioneering neural recordings in patients with Parkinson's disease by UC San Francisco scientists lays the groundwork for personalized brain stimulation to treat Parkinson's and other neurological disorders.
Twenty-six scientists have received a total of $2.06 million in grants from the National Psoriasis Foundation to study psoriasis—the most common autoimmune disease in the country, affecting as many as 7.5 million Americans—and psoriatic arthritis, an inflammatory joint and tendon disease.
There is an exponential use of food additives, especially processed food, due to the significant growth of the global population, changes in lifestyle patterns and demand for nutritious, safe, colourful, flavourful, affordable and convenient food.
› Verified 1 days ago
| Entity Name | Signify Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689158487 PECOS PAC ID: 3274895263 Enrollment ID: O20210303002044 |
News Archive
Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced the pricing of a previously announced underwritten public offering of 3,200,000 shares of its common stock, offered at a price to the public of $0.95 per share.
Research from the Oklahoma Medical Research Foundation reveals a new complexity to nerve cells in the brain that could affect future therapies aimed at altering mood and memory in humans.
Pioneering neural recordings in patients with Parkinson's disease by UC San Francisco scientists lays the groundwork for personalized brain stimulation to treat Parkinson's and other neurological disorders.
Twenty-six scientists have received a total of $2.06 million in grants from the National Psoriasis Foundation to study psoriasis—the most common autoimmune disease in the country, affecting as many as 7.5 million Americans—and psoriatic arthritis, an inflammatory joint and tendon disease.
There is an exponential use of food additives, especially processed food, due to the significant growth of the global population, changes in lifestyle patterns and demand for nutritious, safe, colourful, flavourful, affordable and convenient food.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ellen Marie Farr, MD 2139 Auburn Ave Ste C920b, Cincinnati, OH 45219-2906 Ph: (513) 792-7441 | Ellen Marie Farr, MD 2139 Auburn Ave Ste C920b, Cincinnati, OH 45219-2906 Ph: (513) 792-7441 |
News Archive
Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced the pricing of a previously announced underwritten public offering of 3,200,000 shares of its common stock, offered at a price to the public of $0.95 per share.
Research from the Oklahoma Medical Research Foundation reveals a new complexity to nerve cells in the brain that could affect future therapies aimed at altering mood and memory in humans.
Pioneering neural recordings in patients with Parkinson's disease by UC San Francisco scientists lays the groundwork for personalized brain stimulation to treat Parkinson's and other neurological disorders.
Twenty-six scientists have received a total of $2.06 million in grants from the National Psoriasis Foundation to study psoriasis—the most common autoimmune disease in the country, affecting as many as 7.5 million Americans—and psoriatic arthritis, an inflammatory joint and tendon disease.
There is an exponential use of food additives, especially processed food, due to the significant growth of the global population, changes in lifestyle patterns and demand for nutritious, safe, colourful, flavourful, affordable and convenient food.
› Verified 1 days ago
William Edward Walsh, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6200 Pfeiffer Rd, Fl 3, Cincinnati, OH 45242 Phone: 513-985-6793 Fax: 513-965-8091 | |
Dennis Roy Lockaby Jr., Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1400 Mallard Cove Dr, Cincinnati, OH 45246 Phone: 513-830-5014 | |
David J Kissel, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 6200 Pfeiffer Rd, Fl 3, Cincinnati, OH 45242 Phone: 513-985-6793 Fax: 513-965-8091 | |
Aarti A Singla, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 500 E Business Way, Cincinnati, OH 45241 Phone: 513-354-3700 Fax: 513-354-3705 | |
Dr. James Michael Plunkett, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 3200 Vine St, 117, Cincinnati, OH 45220 Phone: 513-475-6323 Fax: 513-487-6624 | |
Dr. Francis Clifford Valentin, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 7910 Beechmont Ave, Cincinnati, OH 45255 Phone: 513-232-2663 Fax: 859-817-7848 | |
Michelle Miller, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1701 Llanfair Ave # Oh, Cincinnati, OH 45224 Phone: 513-681-4230 |